EichorEICHOR
Condition: Metastatic Malignant Neoplasm In Lymph Node Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Metastatic Malignant Neoplasm In Lymph Node

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Phase 2 · 27 location(s) · University Medical Center Groningen · NCT05076942Identification of Therapeutic Targets in Metastatic Gastric Cancer
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07551440RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
EARLY_Phase 1 · 1 location(s) · Yana Najjar · NCT06216938Lymph Node Mapping Via Flourescent Dye in Colon Cancer
NA · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT04959604Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
NA · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT06840418Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Imple
NA · 14 location(s) · Radboud University Medical Center · NCT07200466Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06621823Total Mesorectal Excision(TME) With Lateral Lymph Node Dissection Versus TME After Neoadjuvant Chemo-radiotherapy
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT03587480Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NA · 98 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT04109079LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes
NA · 6 location(s) · Copernicus Memorial Hospital · NCT06527027HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymp
NA · 1 location(s) · Institut Cancerologie de l'Ouest · NCT06978296Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-can
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06517979Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NA · 1 location(s) · Shanghai Gynecologic Oncology Group · NCT05236686Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
Phase N/A · 1 location(s) · Second Affiliated Hospital of Xi'an Jiaotong University · NCT06286631The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT04403867A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locall
Phase 1/Phase 2 · 2 location(s) · Asan Medical Center · NCT06732856Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06546267Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
Phase N/A · 2 location(s) · Shengjing Hospital · NCT04065321Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometria
NA · 2 location(s) · Dokuz Eylul University · NCT07040657Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
NA · 1 location(s) · Brigham and Women's Hospital · NCT06252129Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis
Phase N/A · 1 location(s) · Anhui Medical University · NCT07112599Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
Phase N/A · 4 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06135571OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06935305Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas
Phase 1 · 1 location(s) · MegaPro Biomedical Co. Ltd. · NCT06540443Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/
Phase N/A · 1 location(s) · Shanghai Chest Hospital · NCT06358222XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction
Phase 2 · 1 location(s) · Xiaofeng Chen · NCT06091423A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Met
Phase 2 · 1 location(s) · Asan Medical Center · NCT05184803Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery
Phase N/A · 12 location(s) · University Hospitals of Derby and Burton NHS Foundation Trus · NCT07085442Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph
Phase N/A · 1 location(s) · Hebei Medical University · NCT06534814Urologic Lymphadenectomy in AMIGO
NA · 1 location(s) · Brigham and Women's Hospital · NCT05132283
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.